Quick Answer
Onconetix, Inc. reported Gross Profit of $632.9 thousand for fiscal year 2025.
Onconetix, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $632.9K | -40.0% |
| 2024 | $1.06M | +193.6% |
| 2023 | -$1.13M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $268.9K | +155.1% | +281.4% |
| June 30, 2025 | $70.5K | -30.0% | +53.8% |
| March 31, 2025 | $45.8K | -75.8% | -56.5% |
| September 30, 2024 | $105.4K | — | +4.7% |
| June 30, 2024 | $100.7K | — | -46.7% |
| March 31, 2024 | $189.0K | — | — |
- Onconetix, Inc. showed a decrease of -40.0% in Gross Profit compared to the prior fiscal year.
- Over the 2023–2025 period, Onconetix, Inc.’s gross profit has grown by 156.2% (from -$1.13 million to $632.9 thousand).
- The most recent figure is from Onconetix, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: